Neonatology

Original Paper

Prescription of Home Oxygen Therapy to Infants in Germany

Peter C. · Poets C.F.

Author affiliations

Department of Neonatology and Paediatric Pulmonology, Hannover Medical School, Hannover, Germany

Related Articles for ""

Biol Neonate 2001;80:148–151

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: August 15, 2001
Issue release date: August 2001

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

There is no consensus on home oxygen therapy in infancy. We hypothesised that this might lead to considerable variability in the practice of prescribing home oxygen to infants. To assess this variability, a structured questionnaire was sent to all departments of Paediatrics in Germany (n = 380). Response rate was 92% (n = 349). Indications were mostly (86%) based on long-term recordings of pulse oximeter saturation (SPO2). There was, however, a wide range (85–94%, mean 90%) of SPO2-values below which oxygen therapy was considered indicated. Hospitals more experienced with this therapy tended to prescribe oxygen at SPO2 values closer to the physiological range. Similarly, SPO2 values aimed for during therapy ranged from 86 to 100%, with hospitals prescribing home oxygen more frequently aiming for higher values. These differences would argue for concentrating home oxygen therapy to centers with the largest experience.

© 2001 S. Karger AG, Basel




Related Articles:


References

  1. Pinney MA, Cotton EK: Home management of bronchopulmonary dysplasia. Pediatrics 1976;58:856–869
    External Resources
  2. Matthys H, Würtemberger G: Empfehlungen zur Sauerstoff-Langzeit-Therapie bei schwerer chronischer Hypoxämie. Pneumologie 1993;47:2–4.
  3. Tarpy SP, Celli BR: Long-term oxygen therapy. N Engl J Med 1995;333:710–714.
  4. Gray PH, Rogers Y: Are infants with bronchopulmonary dysplasia at risk for sudden infant death syndrome? Pediatrics 1994;93:774–777.
  5. Werthammer J, Brown ER, Neff RK, Taeusch HW: Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics 1982;69:301–304.
    External Resources
  6. Lagercrantz H, Ahlström H, Jonson B, Lindroth M, Svenningsen N: A critical oxygen level below which irregular breathing occurs in preterm infants; in von Euler C, Lagercrantz H (eds): Central Nervous Control Mechanisms in Breathing. Oxford, Pergamon Press, 1978, pp 161–164.
  7. McEvoy C, Durand M, Hewlett V: Episodes of spontaneous desaturations in infants with chronic lung disease at two different levels of oxygenation. Pediatr Pulmonol 1993;15:140–144.
  8. Groothuis JR, Rosenberg AA: Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia. Am J Dis Child 1987;141:992–995.
  9. Baraldi E, Carra S, Vencato F, Filippone M, Trevisanuto D, Milanesi O, Pinello M, Zanardo V, Zacchello F: Home oxygen therapy in infants with bronchopulmonary dysplasia: A prospective study. Eur J Pediatr 1997;156:878–882.
  10. Zinman R, Franco I, Pizzuti-Daechsel R: Home oxygen delivery system for infants. Pediatr Pulmonol 1985;1:325–327.
    External Resources
  11. Lindenmann H, Hüls G: Sauerstoff-Langzeittherapie bei Säuglingen und Kleinkindern. Kinderarzt 1991;22:1421–1424.
  12. Poets CF, Stebbens VA, Alexander JR, Arrowsmith WA, Salfield SAW, Southall DP: Arterial oxygen saturation in preterm infants at discharge from the hospital and 6 weeks later. J Pediatr 1992;120:447–454.
  13. Poets CF: Ambulante Sauerstofftherapie: Indikationen, Durchführung und Überwachung. Monatsschr Kinderheilkd 1996;144:1198–1205.
    External Resources
  14. Lock SH, Blower G, Prynne M, Wedzicha JA: Comparison of liquid and gaseous oxygen for domiciliary portable use. Thorax 1992;47:98–1008.
  15. BOOST Trial Newsletter, Issue 3, Sidney 1998.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: August 15, 2001
Issue release date: August 2001

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP